Depression and Health Outcomes in Refractory Epilepsy
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
To define the benefits of antidepressant treatment or cognitive behavior therapy on mood,
function, and quality of life in persons with depression and refractory epilepsy.
Phase:
Phase 3
Details
Lead Sponsor:
Columbia University
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)